Identification and characterization of a potent and selective HUNK inhibitor for treatment of HER2+ breast cancer
{{output}}
Human epidermal growth factor receptor 2 (HER2)-targeted agents have proven to be effective, however, the development of resistance to these agents has become an obstacle in treating HER2+ breast cancer. Evidence implicates HUNK as an anti-cancer target for pr... ...
